Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1177/2042018816638223 http://scihub22266oqcxt.onion/10.1177/2042018816638223 C4892398!4892398 !27293542     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\27293542 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Ther+Adv+Endocrinol+Metab 2016 ; 7 (3 ): 136-47 Nephropedia Template TP {{tp|p=27293542 |t=2016. Review of vancomycin-induced renal toxicity: an update |pdf=|usr=}}{{27293542 }} gab.com Text Review of vancomycin-induced renal toxicity: an update JO: Ther Adv Endocrinol Metab http://www.kidney.de/pget.php?&tw=1&pmid=27293542 #FOAvip In recent times the use of larger doses of vancomycin aimed at curbing the increasing incidence of resistant strains of Staphylococcus aureus has led to a wider report of acute kidney injury (AKI). Apart from biological plausibility, causality is implied by the predictive association of AKI with larger doses, longer duration, and graded plasma concentrations of vancomycin. AKI is more likely to occur with the concurrent use of nephrotoxic agents, and in critically ill patients who are susceptible to poor renal perfusion. Although most vancomycin-induced AKI cases are mild and therefore reversible, their occurrence may be associated with greater incidence of end-stage kidney disease and higher mortality rate. The strategy for its prevention includes adequate renal perfusion and therapeutic drug monitoring in high-risk individuals. In the near future, there is feasibility of renoprotective use of antioxidative substances in the delivery of vancomycin. Twit Text FOAVip Review of vancomycin-induced renal toxicity: an update ????Ther Adv Endocrinol Metab http://www.kidney.de/pget.php?&tw=1&pmid=27293542 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27293542 #FOAvip English Wikipedia <ref>{{Cite pmid|27293542 }}</ref> Review of vancomycin-induced renal toxicity: an update #MMPMID27293542 Bamgbola O Ther Adv Endocrinol Metab 2016[Jun]; 7 (3 ): 136-47 PMID27293542 show ga In recent times the use of larger doses of vancomycin aimed at curbing the increasing incidence of resistant strains of Staphylococcus aureus has led to a wider report of acute kidney injury (AKI). Apart from biological plausibility, causality is implied by the predictive association of AKI with larger doses, longer duration, and graded plasma concentrations of vancomycin. AKI is more likely to occur with the concurrent use of nephrotoxic agents, and in critically ill patients who are susceptible to poor renal perfusion. Although most vancomycin-induced AKI cases are mild and therefore reversible, their occurrence may be associated with greater incidence of end-stage kidney disease and higher mortality rate. The strategy for its prevention includes adequate renal perfusion and therapeutic drug monitoring in high-risk individuals. In the near future, there is feasibility of renoprotective use of antioxidative substances in the delivery of vancomycin. äReview of vancomycin-induced renal toxicity: an update (epmc).pdf DeepDyve Pubget Overpricing